Endonovo Therapeutics, Inc. SEC filings ENDV

Endonovo Therapeutics, Inc. has 502 filings in SEC EDGAR's recent list, going back to Sep 22, 2011. Its latest annual report, Form 10-K, was filed on Apr 17, 2023 for the period ended Dec 31, 2022. The latest quarterly report (Form 10-Q) was filed on Dec 29, 2023, covering the quarter ended Sep 30, 2023. The most recent current report (Form 8-K) was filed on Jan 3, 2024 (material agreement). The company's fiscal year ends on December 31.

Endonovo Therapeutics, Inc. SEC filings
Form	Description	Filed	Period
8-K	Current report Material agreement	Jan 3, 2024	Dec 29, 2023
8-K	Current report Material agreement	Dec 4, 2023	Dec 4, 2023
8-K	Current report Other events	Oct 12, 2023	Oct 5, 2023
8-K	Current report Material agreement	Mar 29, 2023	Mar 28, 2023
8-K	Current report Material agreement	Sep 27, 2022	Sep 26, 2022
8-K	Current report Officer or director change	Aug 7, 2020	Aug 6, 2020
8-K	Current report Material agreement	May 26, 2020	May 20, 2020
8-K	Current report Other events	May 19, 2020	May 19, 2020
8-K	Current report Other events	Apr 10, 2020	Apr 10, 2020
8-K	Current report Other events	Mar 2, 2020	Mar 2, 2020
8-K	Current report Change to shareholder rights	Feb 3, 2020	Jan 29, 2020
8-K	Current report Change to shareholder rights	Dec 19, 2019	Dec 11, 2019
8-K	Current report Other events	Jun 13, 2019	Jun 10, 2019
8-K	Current report Material agreement	Jan 3, 2019	Jan 1, 2019
8-K	Current report Material agreement	Dec 7, 2018	Dec 6, 2018
8-K	Current report Change to shareholder rights	Sep 24, 2018	Sep 18, 2018
8-K	Current report Material agreement	Aug 14, 2018	Aug 12, 2018
8-K	Current report Material agreement	Dec 28, 2017	Dec 21, 2017
8-K	Current report Material agreement, Acquisition or sale of assets, Change to shareholder rights	Dec 26, 2017	Dec 22, 2017
8-K	Current report Change to shareholder rights	Feb 10, 2017	Feb 7, 2017
8-K	Current report Change to shareholder rights	Jan 18, 2017	Jan 17, 2017
8-K	Current report Agreement ended	Aug 19, 2016	Aug 19, 2016
8-K	Current report Material agreement	Jul 15, 2016	Jul 12, 2016
8-K	Current report Material agreement	Jul 11, 2016	Jul 9, 2016
8-K	Current report Other events	Jun 13, 2016	Nov 30, 2015
8-K	Current report Material agreement	Jan 21, 2015	Jan 20, 2015
8-K	Current report Bylaw or fiscal year change, Shareholder vote results	Jan 24, 2014	Jan 22, 2014
8-K	Current report Material agreement, Acquisition or sale of assets, Unregistered share sale	Nov 19, 2013	Nov 16, 2013
8-K	Current report Bylaw or fiscal year change, Shareholder vote results	Oct 11, 2013	Sep 20, 2013
8-K/A	Amended current report Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events	Apr 9, 2013	Apr 2, 2013
8-K	Current report Material agreement, Other events	Apr 8, 2013	Apr 2, 2013
8-K	Current report Material agreement, Unregistered share sale, Change in control, Officer or director change	Mar 21, 2012	Mar 19, 2012

Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as: ENDV (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Woodland Hills, CA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1528172
Former names: Hanover Portfolio Acquisitions, Inc. (until Jan 24, 2014)

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.